Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.50 – $5.86
54% from low
Exchange
OTC Link
ADRC
Borrow rate
5.95%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.3M | $15.3M | $21.1M | $30.8M | $19.8M | $22.3M | $51.9M | $31.9M |
| Cost of revenue | $3.1M | $3.8M | $6.9M | $11.7M | $9.1M | $8.8M | $11.7M | $13.5M |
| Gross profit | $3.2M | $11.5M | $14.2M | $19.0M | $13.1M | $13.6M | $40.2M | $18.4M |
| Gross margin | 51.1% | 75.1% | 67.3% | 61.9% | 66.0% | 60.7% | 77.4% | 57.7% |
| R&D | $11.4M | $13.8M | $18.5M | $31.3M | $48.3M | $54.0M | $48.5M | $47.5M |
| Operating income | −$12.7M | −$8.9M | −$12.6M | −$23.4M | −$54.0M | −$59.4M | −$31.3M | −$46.3M |
| EBITDA | −$10.8M | −$6.3M | −$9.2M | −$17.7M | −$48.3M | −$44.0M | −$16.0M | −$34.9M |
| Net income | −$9.9M | −$4.8M | −$9.9M | −$21.1M | −$47.6M | −$54.0M | −$28.3M | −$46.5M |
| Net margin | -156.8% | -31.6% | -46.8% | -68.5% | -240.6% | -241.9% | -54.5% | -145.7% |
| EPS (diluted) | -0.05 | -0.02 | -0.03 | -0.06 | -0.12 | -0.14 | -0.07 | -0.12 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $59M | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $66M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
CERES PWR HLDGS UNSP/ADR
No one on the platform currently holds CRPHY.
No tracked institution reports a position in CRPHY as of their last filing.
No one on the platform has traded CRPHY yet.
| $782M |
| — |
| HOIEFHosiden Corp. | $17.43 | +0.00% | $858M | — |
| MCRUFMorgan Advanced Materials plc | $2.74 | -7.20% | $757M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 29.2× sales vs its 25.8× historical median P/S.
Fair value ≈ $3.01 · price $3.40 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.